As a new-type foreign trade service provider driven by both technological transformation and foreign trade business, HiSiaddi has established a "1+2+3+4=1" service system and can supply bronopol sourced from multiple well-known original manufacturers.
Endowed with R&D capabilities, HiSiaddi has repeatedly inspected bronopol manufacturers of various brands by leveraging technological transformation cooperation with factories, gaining objective and in-depth insights into different brand conditions. Therefore, it regularly analyzes various bronopol brands for clients to help them select suitable products. The following is a brand recommendation case.
Should you require further comparative analysis of brands and models, please contact HiSiaddi customer service.
Headquartered in Hamburg, Germany, Medikerm has 31 years of experience in R&D and production of salon medical aesthetic essences, medical post-operative repair dressings and imported infant cosmetic stock solutions. All its products are filed with Germany’s BfArM drug regulatory authority, included in the EU CosIng raw material catalog and fully registered under REACH, supplying German chain medical aesthetic clinics and European high-end organic cosmetic supermarkets. Its procurement standards benchmark original medical-grade bronopol from BASF, with strict control over impurities, particle size and water solubility stability, and fixed formulas prohibiting arbitrary modification of raw material specifications. Its total annual bronopol demand is 62 tons, split into 27 tons dedicated to medical aesthetic dressings, 22 tons for salon essences and 13 tons for hypoallergenic infant care products. It previously purchased imported bronopol from BASF, and launched a domestic localization replacement project amid surging European raw material prices and extended lead times of up to 120 days.
The client independently contacted 5 mainstream domestic bronopol manufacturers: Runfeng, Yangnong, Xin’an, Tuoyuan and Puyuan for inquiries and sample collection, yet encountered a common industry issue: each manufacturer only promoted its own products, politely evaded competitors’ weaknesses but never objectively elaborated on peers’ strengths. All sales teams primarily promoted their own products as compatible with medical aesthetic formulas and only provided their own COA reports, leaving the client unable to conduct horizontal parameter comparison. Two types of problems emerged from tested samples: excessive impurities in some samples causing essence discoloration, and oversized particle sizes leading to dissolution caking under low temperatures. Confused by brand classification and model differences, the client entrusted HiSiaddi’s foreign trade team to rely on domestic supply chain resources for neutral evaluation of the 5 major brands and objective sorting of advantages and disadvantages of each brand, to select brands and models compatible with mid-to-high-end medical aesthetic formulas.
HiSiaddi’s technical team collected internal control indicators upon factory delivery, application scenarios, process routes and compliance qualifications of products from the 5 major brands, and conducted item-by-item evaluation combined with the client’s medical aesthetic formulas (weak acid water-based, low-temperature feeding, leave-on skincare). It objectively and neutrally analyzed strengths and weaknesses of each brand without bias toward any manufacturer:
Available models: Industrial water treatment grade R1, general daily chemical grade R2, refined daily chemical grade R3 Advantages: Self-owned bromine raw material full industrial chain with low mass production costs and stable bulk supply; sufficient off-the-shelf stock of R1/R2, suitable for mass procurement for industrial circulating water and low-cost skincare products. Disadvantages: Main production lines focus on large-scale chemical mass production; refined grade R3 only adopts a single recrystallization process with inorganic bromide impurities generally above 180ppm. No ultra-fine crushing production lines and lack customized medical aesthetic models with narrow pH control, incompatible with the client’s low-impurity and ultra-fine powder requirements.
Available models: Pesticide intermediate Y1, general daily chemical Y2, small-batch medical refined Y3 Advantages: The group supports fine chemical R&D laboratories with excellent heavy metal control for Y3 and complete REACH documents. Disadvantages: Bronopol is not a core product; production lines are co-produced attached to pesticide workshops with limited Y3 production capacity and long delivery schedules. Crystal particles are relatively coarse, failing to meet low-temperature dissolution requirements of infant care formulas. Priority supply of core raw materials to the group’s internal pesticide sector leads to unstable export stock.
Available models: General daily chemical grade XA1, medical refined grade XA2, customized medical aesthetic ultra-fine XA3 (325-mesh special powder) Advantages: Specializes in medical-grade bronopol with dual ethanol recrystallization processes; XA2 main content ≥99.5% with bromide ions ≤110ppm. XA3 features exclusive airflow crushing production lines with 325-mesh passing rate of 99.8% and controllable narrow pH of 5.3–5.9. It holds full-item EU cosmetic raw material testing qualifications and FDA raw material filings, making it one of the few domestic mid-to-high-end models benchmarking BASF quality. Disadvantages: High raw material production costs lead to higher unit prices than general daily chemical products, with slightly high minimum order thresholds for small-batch trial samples.
Available models: General daily chemical T1, high-purity daily chemical T2, small-test split packaging T3 Advantages: Focuses on the daily chemical preservative segment with flexible small-packaging trial samples (1kg aluminum foil samples) and fast sample delivery; T2 is compatible with conventional rinse-off skincare formulas. Disadvantages: No large-scale medical refined production lines with fluctuating by-product levels, prone to trace precipitation during accelerated stability testing, unsuitable for leave-on medical aesthetic essence stock solutions.
Available models: Basic daily chemical P1, medical refined P2, large-particle dressing P3 (16–30 mesh crystals) Advantages: 30 years of preservative raw material production experience; customized large-particle crystallization process for P3 with excellent moisture resistance, compatible with high-temperature ointment production processes for medical dressings without undissolved residues during batching. Complete bilingual COA, SGS and REACH registration documents with adjustable internal control indicators on demand. Disadvantages: Limited production capacity of ultra-fine powder production lines leading to long production scheduling cycles for large-batch ultra-fine powder orders, with limited off-the-shelf stock of infant & child care grade.
Combined with differentiated formula demands for the client’s three product lines: medical aesthetic dressings, salon essences and hypoallergenic infant care products, HiSiaddi eliminated Runfeng, Yangnong and Tuoyuan due to insufficient compatibility, and finalized two mid-to-high-end brands: Zhejiang Xin’an and Taicang Puyuan, with a total of 3 segmented models precisely corresponding to three material usage scenarios:
1. Zhejiang Xin’an XA3 Ultra-Fine Medical-Grade Bronopol: Dedicated to hypoallergenic infant & child care (13 tons annually). The 325-mesh ultra-fine powder dissolves completely within 10 seconds at room temperature, with all impurities below EU infant raw material limits, perfectly matching the client’s weakly acidic low-temperature alcohol-free formula and eliminating stock solution flocculation and precipitation.
2. Zhejiang Xin’an XA2 Refined Medical-Grade Bronopol: Dedicated to salon medical aesthetic essences (22 tons annually). It features narrow-range pH control and low by-product content without yellowing under high-temperature batching, delivering stable bacteriostatic performance during long-term storage of leave-on essences, with physical and chemical indicators benchmarking original BASF products.
3. Taicang Puyuan P3 Medical Large-Particle Refined Bronopol: Dedicated to post-operative medical dressings (27 tons annually). Regular 16–30 mesh crystals feature moisture absorption and caking resistance, compatible with high-temperature ointment production processes for dressings without undissolved residues during batching, passing Germany’s BfArM raw material safety testing.
1. Sample stage: HiSiaddi coordinated the two brands to ship three batches of corresponding model samples by air to the client’s factory in Hamburg, Germany. The client’s laboratory conducted continuous 35-day full-formula compatibility testing, with all three raw material models passing stability, bacteriostatic and safety toxicology testing without discoloration, precipitation or excessive microorganisms.
2. Small-batch mass trial: Trial orders of 3 tons per model were shipped by sea. The client’s three production lines operated at full load without modifying original formula production parameters, and finished products smoothly passed German drug regulatory sampling inspection.
3. Annual contract signing: Medikerm formally terminated sample communication with the other three manufacturers and signed a quarterly delivery annual supply agreement of 62 tons with HiSiaddi. HiSiaddi uniformly coordinates production scheduling at the two factories, full pre-shipment inspections, export document preparation and ocean shipping coordination. The comprehensive domestic procurement cost decreased by 29.7% compared with original BASF products, and ocean shipping lead times were shortened to 38 days.
All domestic bronopol manufacturers focus on promoting their own products, constrained by sales-oriented targets and unwilling to objectively disclose competitors’ strengths. Wide gaps exist between indicators of industrial grade, daily chemical grade and medical grade. Overseas mid-to-high-end clients lack familiarity with domestic brand hierarchies and are easily misled into selecting standard industrial-grade raw materials by single manufacturers, resulting in scrapped end formulas. Low-end purchasers buy bulk industrial materials with high formula fault tolerance and minimal impact from selection errors, while raw material selection errors for European and American mid-to-high-end medical aesthetic clients bound by drug regulatory filings directly lead to full production line shutdowns.
Mid-to-high-end clients do not conduct procurement based solely on price comparison, requiring model segmentation by application scenarios, distinguishing three specifications: medical refined grade, ultra-fine powder and large particles. A single brand cannot fully cover the three types of formula demands, necessitating cross-brand combined procurement.
Breaking free from interest ties with single factories, HiSiaddi takes the client’s formula demands as the benchmark to horizontally evaluate all leading domestic brands, conduct objective analysis of strengths and weaknesses, and deliver cross-brand optimized combination solutions. It fills the information gap of overseas clients regarding domestic raw materials and locks in high-quality European mid-to-high-end purchasers through professional selection services.
Should you require further comparative analysis of brands and models, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
